Dianthus Therapeutics, Inc. /DE/
Dianthus Therapeutics, Inc. /DE/ (DNTH) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 30 transactions totaling $10.4M, demonstrating a bearish sentiment with -$7.5M in net insider flow. The most recent transaction on Feb 3, 2026 involved a transaction of 355,000 shares valued at $0.
DNTH Insider Activity Summary
Who Is Buying DNTH Stock?
No significant insider buying has been recorded for DNTH in the recent period.
Who Is Selling DNTH Stock?
No significant insider selling has been recorded for DNTH in the recent period.
Is Dianthus Therapeutics, Inc. /DE/ Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for DNTH is bearish with an Insider Alignment Score of 14/100 and a net flow of -$7.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
DNTH Frequently Asked Questions
Understanding DNTH Insider Activity
Insider trading at Dianthus Therapeutics, Inc. /DE/ (DNTH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading DNTH stock, having executed 30 transactions in the past 90 days. The most active insider is Partners Management (gp) Llc Avidity (Executive), who has made 1 transactions totaling $18.0M.
Related Tools
Track Dianthus Therapeutics, Inc. /DE/ Insider Activity
Get notified when executives and directors at DNTH file new Form 4 transactions